XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.22.0.1

STOCKHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Stockholders' Equity Note [Abstract] |
Schedule of Accumulated Other Comprehensive Income (Loss) | Changes in AOCI by component, net of tax, for the years ended December 31, 2021, 2020, and 2019 are summarized as follows (in thousands):
|  | Foreign Currency Translation |  | Derivative Instruments |  | Total
Balances at December 31, 2018 |  | $ | (2,578) |  |  | $ | (765) |  |  | $ | (3,343) |
Net unrealized gains (losses) arising during the period(a) |  | 712 |  |  | (3,059) |  |  | (2,347) |
Less: Net realized gains (losses) reclassified to net income(b) |  | — |  |  | (1,712) |  |  | (1,712) |
Net change during the period |  | 712 |  |  | (1,347) |  |  | (635) |
Balances at December 31, 2019 |  | (1,866) |  |  | (2,112) |  |  | (3,978) |
Net unrealized gains (losses) arising during the period(c) |  | (316) |  |  | 6,111 |  |  | 5,795 |
Less: Net realized gains (losses) reclassified to net loss(d) |  | — |  |  | (5,816) |  |  | (5,816) |
Net change during the period |  | (316) |  |  | 11,927 |  |  | 11,611 |
Balances at December 31, 2020 |  | (2,182) |  |  | 9,815 |  |  | 7,633 |
Net unrealized gains (losses) arising during the period(e) |  | 193 |  |  | 34,127 |  |  | 34,320 |
Less: Net realized gains (losses) reclassified to net income(f) |  | — |  |  | 41,094 |  |  | 41,094 |
Net change during the period |  | 193 |  |  | (6,967) |  |  | (6,774) |
Balances at December 31, 2021 |  | $ | (1,989) |  |  | $ | 2,848 |  |  | $ | 859 |
————————— (a) Derivative instruments net of $1.0 million of tax benefit for the year ended December 31, 2019. (b) Derivative instruments net of $0.6 million of tax benefit for the year ended December 31, 2019. (c) Derivative instruments net of $2.1 million of tax expense for the year ended December 31, 2020. (d) Derivative instruments net of $2.0 million of tax benefit for the year ended December 31, 2020. (e) Derivative instruments net of $11.5 million of tax expense for the year ended December 31, 2021. (f) Derivative instruments net of $13.8 million of tax expense for the year ended December 31, 2021.

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration